Blunted prolactin response to fentanyl in depression. Normalizing effect of partial sleep deprivation

Psychiatry Research

Volumn 118, Issue 2, 2003, Pages 155-164

  Frecska, Ede ^a   Perenyi, Andras ^b   Arato, Mihaly ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Clayton Comm Mental Health Service   (Australia)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Affective disorders; Antidepressants; Dopamine; Monoamines; Opiates; Opioids; Serotonin

Indexed keywords

DOPAMINE; FENTANYL; MU OPIATE RECEPTOR AGONIST; OPIATE; OPIATE AGONIST; PLACEBO; PROLACTIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOPAMINE RELEASE; DRUG EFFECT; DRUG MECHANISM; FEMALE; HORMONE RESPONSE; HOSPITAL PATIENT; HUMAN; MENTAL PATIENT; NIGHT SLEEP; PRIORITY JOURNAL; PROLACTIN RELEASE; PROVOCATION TEST; SLEEP DEPRIVATION; SLEEP DISORDER;

EID: 0037870092     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(03)00072-6     Document Type: Article

References (63)

1. Adler L.J., Gyulai F.E., Diehl D.J., Mintun M.A., Winter P.M., Firestone L.L. Regional brain activity changes associated with fentanyl analgesia elucidated by positron emission tomography. Anesthesia and Analgesia. 84:1997;120-126.
2. Diagnostic and Statistical Manual of Mental Disorders. fourth ed :1994;American Psychiatric Press, Washington, DC.
3. Asikainen M., Toppila J., Alanko L., Ward D.J., Stenberg D., Porkka-Heiskanen T. Sleep deprivation increases brain serotonin turnover in the rat. NeuroReport. 8:1997;1577-1582.
4. Banki C.M., Arato M. Multiple hormonal responses to morphine: relationship to diagnosis and dexamethasone suppression. Psychoneuroendocrinology. 12:1987;3-11.
5. Baumgartner A., Riemann D., Berger M. Neuroendocrinological investigations during sleep deprivation in depression. II. Longitudinal measurement of thyrotropin, TH, cortisol, prolactin, GH, and LH during sleep and sleep deprivation. Biological Psychiatry. 28:1990;569-587.
6. Ben-Jonathan N., Arbogast L.A., Hyde J.F. Neuroendocrine regulation of prolactin release. Progress in Neurobiology. 33:1989;399-447.
7. Benedetti F., Serretti A., Colombo C., Campori E., Barbini B., di Bella D., Smeraldi E. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. American Journal of Psychiatry. 156:1999;1450-1452.
8. Benedetti F., Campori E., Barbini B., Fulgosi M.C., Colombo C. Dopaminergic augmentation of sleep deprivation effects in bipolar depression. Psychiatry Research. 104:2001;239-246.
9. Bjorvatn B., Gronli J., Hamre F., Sorensen E., Fiske E., Bjorkum A.A., Portas C.M., Ursin R. Effects of sleep deprivation on extracellular serotonin in hippocampus and frontal cortex of the rat. Neuroscience. 113:2002;323-330.
10. Borbély A.A., Steigrad P., Tobler I. Effect of sleep deprivation on brain serotonin in the rat. Behavioural Brain Research. 1:1980;205-210.
11. Calcagnetti D.J., Holtzman S.G. Potentiation of morphine analgesia in rats given a single exposure to restraint stress immobilization. Pharmacology, Biochemistry and Behaviour. 41:1992;449-453.
12. Casey K.L., Svensson P., Morrow T.J., Raz J., Jone C., Minoshima S. Selective opiate modulation of nociceptive processing in the human brain. Journal of Neurophysiology. 84:2000;525-533.
13. Contreras C.M., Marvan M.L., Alcala-Herrera V. Sleep deprivation is a less potent agent than clomipramine in increasing firing rate in lateral septal neurons in the rat. Neuropsychobiology. 27:1993;83-85.
14. Demarest K.T., Moore K.E. Disruption of 5-hydroxytryptaminergic neuronal function blocks the action of morphine on tuberoinfundibular dopaminergic neurons. Life Sciences. 28:1981;1345-1351.
15. Ebert D., Berger M. Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation. Psychopharmacology. 140:1998;1-10.
16. Ebert D., Kaschka W. Humoral aspects of sleep deprivation [German]. Fortschritte der Neurologie-Psychiatrie. 63:1995;441-450.
17. Ebert D., Kaschka W., Stegbauer P., Schrell U. Prolactin response to sulpiride before and after sleep deprivation in depression. Biological Psychiatry. 33:1993;666-669.
18. Ebert D., Feistel H., Kaschka W., Barocka A., Pirner A. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation - preliminary results. Biological Psychiatry. 35:1994;880-885.
19. Extein I., Pottash A.L., Gold M.S., Sweeney D.R., Martin D.M., Goodwin F.K. Deficient prolactin response to morphine in depressed patients. American Journal of Psychiatry. 137:1980;845-846.
20. Fadda P., Martellotta M.C., Gessa G.L., Fratta W. Dopamine and opioid interactions in sleep deprivation. Progress in Neuro-Pychopharmacology and Biological Psychiatry. 17:1993;269-278.
21. Franklin M., Craven R.D., Dowling B., Campling G., Elliott J.M., Cowen P.J. Effect of a long-term low tryptophan diet on the prolactin responses to the 5-HT1A and 5-HT2C agonists, 8-OH-DPAT and mCPP, in the male rat. Journal of Psychopharmacology. 13:1999;58-63.
22. Fratta W., Collu M., Martellotta M.C., Pichiri M., Muntoni F., Gessa G.L. Stress-induced insomnia: opioid-dopamine interactions. European Journal of Pharmacology. 142:1987;437-440.
23. Frecska E., Arato M., Banki C.M., Bagdy G., Perenyi A., Mohari K., Fekete M.I. Diurnal variation in fentanyl-induced hormone responses and side effects. Neuropsychopharmacology. 1:1988;235-238.
24. Frecska E., Arato M., Banki C.M., Mohari K., Perenyi A., Bagdy G., Fekete M.I. Prolactin response to fentanyl in depression. Biological Psychiatry. 25:1989;692-696.
25. Frecska E., Arato M. Opiate sensitivity test in patients with stereotypic movement disorder and trichotillomania. Progress in Neuro-Pychopharmacology and Biological Psychiatry. 26:2002;909-912.
26. Gardner J.P., Fornal C.A., Jacobs B.L. Effects of sleep deprivation on serotonergic neuronal activity in the dorsal raphe nucleus of the freely moving cat. Neuropsychopharmacology. 17:1997;72-81.
27. Gehde E., Emrich H.M. Systemteoretische konzepte zur wirkung des schlafentzuges. Kasper S., Möller H.J. Therapeutischer Schlafentzug. 1996;229-263 Springer, Wien.
28. Gelenberg A.J., Chesen C.L. How fast are antidepressants? Journal of Clinical Psychiatry. 61:2000;712-721.
29. Gessa G.L., Pani L., Serra G., Fratta W. Animal models of mania. Advances in Biochemical Psychopharmacology. 49:1995;43-66.
30. Gillin J.C., Buchsbaum M., Wu J., Clark C., Bunney W. Jr. Sleep deprivation as a model experimental antidepressant treatment: findings from functional brain imaging. Depression and Anxiety. 14:2001;37-49.
31. Hodgson D.M., Bond N.W. Control of food delivery in food-deprived rats mediates analgesia. Behavioural Brain Research. 44:1991;205-209.
32. Uniform requirements for manuscripts submitted to biomedical journals. The Journal of the American Medical Association. 277:1997;927-934.
33. Jones A.K., Qi L.Y., Fujirawa T., Luthra S.K., Ashburner J., Bloomfield P., Cunningham V.J., Itoh M., Fukuda H., Jones T. In vivo distribution of opioid receptors in man in relation to the cortical projections of the medial and lateral pain systems measured with positron emission tomography. Neuroscience Letters. 126:1991;25-28.
34. Judd L.L., Risch S.C., Parker D.C., Janowsky D.S., Segal D.S., Huey L.Y. Blunted prolactin response: a neuroendocrine abnormality manifested by depressed patients. Archives of General Psychiatry. 39:1982;1413-1416.
35. Kasper S., Vieira A., Wehr T.A., Schmidt R., Kick H., Voll G., Murphy D.L. Serotonergically induced hormonal responses and the antidepressant effect of total sleep deprivation in patients with major depression. Psychopharmacology Bulletin. 24:1988;450-453.
36. Kasper S., Sack D.A., Wehr T.A., Kick H., Voll G., Vieira A. Nocturnal TSH and prolactin secretion during sleep deprivation and prediction of antidepressant response in patients with major depression. Biological Psychiatry. 24:1988;631-641.
37. Koenig J.I. Pituitary gland: neuropeptides, neurotransmitters and growth factors. Toxicologic Pathology. 17:1989;256-265.
38. Kuhs H., Tölle R. Sleep deprivation therapy. Biological Psychiatry. 29:1991;1129-1148. Review.
39. Loose M.D., Ronnekleiv O.K., Kelly M.J. Membrane properties and response to opioids of identified dopamine neurons in the guinea pig hypothalamus. Journal of Neuroscience. 10:1990;3627-3634.
40. Matthews J.N., Altman D.G., Campbell M.J., Royston P. Analysis of serial measurements in medical research. British Medical Journal. 300:1990;230-235.
41. Meltzer H.Y., Maes M. Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man. Psychopharmacology. 114:1994;635-643.
42. Minamitani N., Minamitani T., Lechan R.M., Bollinger-Gruber J., Reichlin S. Paraventricular nucleus mediates prolactin secretory responses to restraint stress, ether stress, and 5-hydroxy-L-tryptophan injection in the rat. Endocrinology. 120:1987;860-867.
43. Moore K.E., Lookingland K.J. Dopaminergic neuronal systems in the hypothalamus. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;245-256 Raven Press, New York.
44. Neumeister A., Praschak-Rieder N., Hesselmann B., Vitouch O., Rauh M., Barocka A., Tauscher J., Kasper S. Effects of tryptophan depletion in drug-free depressed patients who responded to total sleep deprivation. Archives of General Psychiatry. 55:1998;167-172.
45. Neumeister A., Praschak-Rieder N., Willeit M., Stastny J., Kasper S. Monoamine depletion in non-pharmacological treatments for depression. Advances in Experimental Medicine and Biology. 467:1999;29-33.
46. Nicholas L., Dawkins K., Golden R.N. Psychoneuroendocrinology of depression. Prolactin. Psychiatric Clinics of North America. 21:1998;341-358.
47. Pflug B., Tölle R. Therapy of endogenous depressions using sleep deprivation. Practical and theoretical consequences [German]. Nervenarzt. 42:1971;117-124.
48. Prevot E., Maudhuit C., Le Poul E., Hamon M., Adrien J. Sleep deprivation reduces the citalopram-induced inhibition of serotoninergic neuronal firing in the nucleus raphe dorsalis of the rat. Journal of Sleep Research. 5:1996;238-245.
49. Preziosi P., Vacca M., Cerrito F. Serotonergic and endogenous opiates interplay in the control of ACTH and prolactin release. Archives Internationales de Pharmacodynamie et de Thérapie. 263:1983;325-327.
50. Rudolf G.A., Tölle R. Sleep deprivation and circadian rhythm in depression. Psychiatria Clinica. 11:1978;198-212.
51. Schilgen B., Tölle R. Partial sleep deprivation as therapy for depression. Archives of General Psychiatry. 37:1980;267-271.
52. Seibyl J.P., Krystal J.H., Price L.H., Woods S.W., D'Amico C., Heninger G.R., Charney D.S. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects. Psychiatry Research. 38:1991;227-236.
53. Seifritz E., Müller M.J., Annen O., Nil R., Hatzinger M., Hemmeter U., Moore P., Holsboer-Trachsler E. Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects. Journal of Psychiatric Research. 31:1997;543-554.
54. Smeraldi E., Benedetti F., Barbini B., Campori E., Colombo C. Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial. Neuropsychopharmacology. 20:1999;380-385.
55. Sutton L.C., Lea S.E., Will M.J., Schwartz B.A., Hartley C.E., Poole J.C., Watkins L.R., Maier S.F. Inescapable shock-induced potentiation of morphine analgesia. Behavioral Neuroscience. 111:1997;1105-1113.
56. Tsai L.L., Bergmann B.M., Perry B.D., Rechtschaffen A. Effects of chronic total sleep deprivation on central noradrenergic receptors in rat brain. Brain Research. 602:1993;221-227.
57. Volk S.A., Kaendler S.H., Hertel A., Maul F.D., Manoocheri R., Weber R., Georgi K., Pflug B., Hor G. Can response to partial sleep deprivation in depressed patients be predicted by regional changes of cerebral blood flow? Psychiatry Research. 75:1997;67-74.
58. Wesemann W., Weiner N., Rotsch M., Schulz E. Serotonin binding in rat brain: circadian rhythm and effect of sleep deprivation. Journal of Neural Transmission Supplementum. 18:1983;287-294.
59. Schedules for Clinical Assessment in Neuropsychiatry. 1994;American Psychiatric Press, Washington, DC.
60. Wirz-Justice A., Van den Hoofdakker R.H. Sleep deprivation in depression: what do we know, where do we go? Biological Psychiatry. 46:1999;445-453.
61. Wu J.C., Bunney W.E. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. American Journal of Psychiatry. 147:1990;14-21.
62. Wu J., Buchsbaum M.S., Gillin J.C., Tang C., Cadwell S., Wiegand M., Najafi A., Klein E., Hazen K., Bunney W.E. Jr., Fallon J.H., Keator D. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. American Journal of Psychiatry. 156:1999;1149-1158.
63. Zis A.P., Haskett R.F., Albala A.A., Carroll B.J., Lohr N.E. Prolactin response to morphine in depression. Biological Psychiatry. 20:1985;287-292.